retatrutide clinical trial results weight loss 2024 2025 press release Results: 28.3% Data Retatrutide: The Triple Agonist That's

The Untold Truths At Six Weeks Out If youre going through prep for the first time, you will experience a roller-coaster of emotions and feelings that you didnt know were part of it when you started dieting

Pull the plunger back to your target unit number, drawing air into the syringe equal to the volume you intend to withdraw

7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks

Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, et al

10.1016/j.jalz.2013.12.009 294